Phase 3 Newborn Clinical Trials
10 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–10 of 10 trials
Recruiting
Phase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC120 enrolled61 locationsNCT05912517
Recruiting
Phase 3
Cooling in Mild Encephalopathy
Neonatal EncephalopathyNewborn Asphyxia
Imperial College London426 enrolled39 locationsNCT05889507
Recruiting
Phase 3
The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes
Newborn HealthNeurodevelopment OutcomeMultiple Micronutrient Deficiencies During Pregnancy+3 more
Aga Khan University3,000 enrolled1 locationNCT07029282
Recruiting
Phase 2Phase 3
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Respiratory DiseaseVentilator Lung; NewbornPrematurity
Ministry of Health, Saudi Arabia134 enrolled2 locationsNCT06026163
Recruiting
Phase 3
Safeguarding the Brain of Our Smallest Children-IIIv (SafeBoosC-IIIv)
HypoxiaInfant, Newborn, Diseases
Copenhagen Trial Unit, Center for Clinical Intervention Research1,610 enrolled1 locationNCT05907317
Not Yet Recruiting
Phase 3
"Breathing in Newborns: Evaluating the Impact of Salbutamol, Furosemide, and Their Combination on Newborn Breathing at CMH Peshawar's Neonatal Intensive Care Unit"
Transient Tachypnea of the Newborn
Dr.Aamir Iqbal200 enrolled1 locationACTRN12624000987561
Recruiting
Phase 3
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
EncephalopathyErythropoietinNewborn Asphyxia
Imperial College London504 enrolled10 locationsNCT05395195
Recruiting
Phase 3
PRECeDe Trial: Prevention of neonatal Respiratory distress with antenatal corticosteroids prior to Elective Caesarean section in women with Diabetes: a Randomised Controlled Trial
transient tachypnoea of newborn
The University of Melbourne2,200 enrolled14 locationsACTRN12623000015640
Recruiting
Phase 3
The C*STEROID Trial: Corticosteroids before planned caesarean section from 35+0 to 39+6 weeks of pregnancy.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
The University of Auckland2,548 enrolled23 locationsACTRN12620000914965
Terminated
Phase 3
The C*STEROID Feasibility Study: a two-site, randomised placebo controlled trial of corticosteroids before planned caesarean section delivery at 35+0 to 39+6 weeks of pregnancy to determine feasibility for recruitment to the C*STEROID Trial.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
University of Auckland400 enrolled1 locationACTRN12618002028280